Last update 08 May 2025

NET x SLC6A20

Basic Info

Related Targets
NETSLC6A20

Related

1
Drugs associated with NET x SLC6A20
18F-NS-12137
Target
NET x SLC6A20
Mechanism
NET agonists [+1]
Active Org.
DanPET ABDanPET AB [+1]
Originator Org.
University of TurkuUniversity of Turku [+1]
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with NET x SLC6A20
CTIS2024-517531-40-00
/ Not yet recruitingPhase 1IIT
Dosimetry, kinetics and test-retest properties of a novel norepinephrine transporter radiotracer [18F]NS12137
100 Clinical Results associated with NET x SLC6A20
Login to view more data
100 Translational Medicine associated with NET x SLC6A20
Login to view more data
0 Patents (Medical) associated with NET x SLC6A20
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free